CAD Mammography Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 1.10 Bn

Forecast Year, 2035

USD 2.70 Bn

CAGR, 2026 - 2035

9.40%

Report Coverage

Global

What is the CAD Mammography Market Size in 2026?

The global CAD mammography market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.20 billion in 2026 to approximately USD 2.70 billion by 2035, expanding at a CAGR of 9.40% from 2026 to 2035. The market growth is attributed to rising breast cancer screening volumes and growing demand for early and accurate diagnosis.

Key Takeaways

• North America dominated the CAD mammography market with a 40% share in 2025.
• Asia Pacific is expected to grow at the fastest CAGR of 10.5% between 2026 and 2035.
• By type, the 3D mammography segment held the highest market share of 55% in 2025.
• By type, the 2D mammography segment held a 45% share of the market in 2025 and is expected to grow at a significant CAGR of 7% between 2026 and 2035.
• By technology, the full-field digital mammography (FFDM) segment held a major market share of 60% in 2025.
• By technology, the contrast-enhanced mammography segment is expected to grow at a 16% CAGR during the projection period.
• By end-use, the hospitals segment held the highest market share of 55% in 2025.
• By end-use, the diagnostic imaging centers segment held the second-largest market share of 25% in 2025 and is estimated to grow at a strong CAGR of 8% over the projected period.

Market Overview

The rising global burden of breast cancer and the expansion of screening programs are key factors driving the growth of the CAD mammography market . According to the World Health Organization, breast cancer accounts for over 2.3 million new cases annually worldwide. Mammography is an imaging technique that uses low-dose X-rays to detect tumors at early stages, significantly improving survival rates through early diagnosis.

Computer-aided detection (CAD) enhances mammography by using AI algorithms to identify suspicious lesions and abnormal tissue patterns with greater accuracy. Additionally, the increasing workload on radiologists is encouraging healthcare providers to adopt CAD systems to improve diagnostic efficiency, accuracy, and overall workflow productivity.

Impact of Artificial Intelligence on the CAD Mammography Market

Artificial intelligence is revolutionizing the market by improving the way Imaging systems detect and interpret the early breast cancer signs. AI-based CAD systems are proactive in examining mammograms and assisting radiologists with real-time decision support. AI technologies are being embraced more by healthcare providers as a way of managing increasing imaging volumes and reducing diagnostic delays. Furthermore, AI also facilitates automatic breast density testing and customized risk testing, enhancing the screening reliability for a broad spectrum of patients.

Major Market Trends

• Demand for High Accuracy Imaging & Individualized Screening: There is a rapid shift toward high-accuracy imaging because early and precise detection of breast cancer significantly improves patient outcomes and reduces false positives and missed diagnoses. Individualized screening is also gaining traction, enabling risk-based and patient-specific screening approaches, where CAD helps tailor analysis based on individual breast density, history, and risk factors.
• Advancements in Deep Learning Algorithms: Continuous improvements in AI model accuracy are propelling confidence and wider clinical use of CAD in mammography.
• Rising Focus on Value-Based Healthcare Delivery: Healthcare systems are increasingly adopting CAD tools to improve diagnostic outcomes while optimizing operational costs.

Market Scope

Market Dynamics

Drivers

Rising Breast Cancer Incidence

The increasing incidence of breast cancer worldwide is a major factor driving the demand for screening, and so is the market growth. The growing requirement for screening and detection of breast cancer is projected to create a need for sophisticated imaging solutions. According to the World Cancer Research Fund, 321,910 new breast cancer cases were reported in 2026, highlighting the growing global disease burden. In response, healthcare systems are expanding organized screening programs to improve early detection. Furthermore, rising radiologist workloads and workforce shortages are increasing demand for automated diagnostic support systems.

Restraint

High Implementation and Integration Costs

High implementation and integration costs of CAD mammography systems are expected to limit the adoption across healthcare facilities, thus hindering market growth. Modern mammography systems with built-in AI CAD need significant capital investment into hardware and software solutions. Furthermore, innovation in healthcare is often constrained by cost sensitivity, which continues to limit the adoption of premium CAD-enabled solutions.

Opportunity

Ongoing Advancements

Advancements in CAD mammography technologies are expected to create significant opportunities for market players. Ongoing progress in artificial intelligence and deep learning algorithms is enhancing the clinical adoption of CAD systems by improving diagnostic accuracy and efficiency. Additionally, the growing emphasis on early detection and preventive healthcare is further driving demand for advanced mammography solutions.

Segment Insights

Type Insights

The 3D Mammography Segment Dominated the Market With a 55% Share in 2025

The 3D mammography (Tomosynthesis) segment held the largest share of 55% in the CAD mammography market in 2025 and is expected to sustain its leading position in the coming years. This is mainly due to its superior imaging capabilities that support accurate and early detection of cancer. Improved lesion visibility and diagnostic capabilities are making tomosynthesis systems the preferred choice of healthcare providers. 3D mammography provides radiologists with a clearer picture, allowing them to better distinguish between benign and malignant tumors.

CAD Mammography Market Share, By Type, 2025-2035 (%)

The 2D mammography segment held the second-largest market share of 45% in 2025 and is expected to grow at a CAGR of 7% between 2026 and 2035. This is mainly due to its lower cost, simplicity, and established clinical use in breast cancer detection. CAD features are being integrated into existing 2D mammography platforms to improve detection accuracy without requiring major changes to existing healthcare infrastructure. Additionally, public healthcare screening programs continue to prioritize 2D imaging to maximize patient coverage and accessibility, thereby supporting segment growth.

Technology Insights

CAD Mammography Market Share, By Technology, 2025-2035 (%)

Why Did the Full-Field Digital Mammography (FFDM) Segment Dominated the Market in 2025?

The full-field digital mammography (FFDM) segment dominated the CAD mammography market with the highest share of 60% in 2025, as this technology is widely used by imaging centers. FFDM systems are also used by healthcare providers in routine screening as they provide uniform image quality. The technology is fully compatible with PACS and AI-based CAD systems and enhances the accuracy of the diagnosis and the continuity of the work.

The analog mammography segment held a 15% share of the market in 2025 and is expected to grow at a 3% CAGR during the forecast period. The growth of the segment is driven by the rising demand for specialized and decentralized imaging services across urban and semi-urban regions. Healthcare facilities in low-resource settings still use analog systems for their low cost.

The digital breast tomosynthesis (DBT) segment held a 15% market share in 2025 and is estimated to grow at a strong CAGR of 13% over the projected period. This is mainly due to the growing focus on early detection and preventive healthcare strategies. Medical practitioners are becoming more inclined to use DBT systems to enhance screening accuracy and lower the recall rates.

The contrast-enhanced mammography (CEM) segment held a 10% share of the CAD mammography market in 2025 and is expected to grow at a CAGR of 16% between 2026 and 2035. This is because this technology aids in visualizing abnormal tissue with the aid of contrast agents, which is more effective in detecting vascularized lesions.

End-Use Insights

CAD Mammography Market Share, By End-Use, 2025-2035 (%)

Hospitals Dominated the Market With a 55% Share in 2025

The hospitals segment dominated the CAD mammography market with the largest share of 55% in 2025, owing to their central role in advanced diagnostic imaging services. Hospitals typically have dedicated radiology departments and multi-modality imaging suites, enabling seamless integration of CAD platforms into existing workflows. They are also leading adopters of AI-enabled systems from companies such as GE HealthCare and Siemens Healthineers to enhance diagnostic accuracy and efficiency.

The diagnostic imaging centers segment held a 25% share of the market in 2025 and is expected to grow at a CAGR of 8% during the forecast period. This growth is driven by the increasing demand for specialized imaging procedures. These centers are rapidly adopting advanced CAD-enabled systems to improve diagnostic accuracy, enhance service efficiency, and manage rising outpatient imaging volumes. According to the American College of Radiology, outpatient imaging volumes have steadily increased during 2024-2025. Additionally, partnerships with technology firms such as Volpara Health Technologies are further strengthening CAD integration in diagnostic imaging centers.

The breast cancer screening clinics segment held a 10% share of the market in 2025 and is estimated to grow at a strong CAGR of 9% over the projected period. The growth of the segment is driven by the increasing focus on early detection and preventive healthcare strategies. These clinics primarily cater to high-risk populations by offering targeted screening services for early diagnosis and intervention.

Regional Insights

North America CAD Mammography Market Size and Growth 2026 to 2035

The North America CAD mammography market size is estimated at USD 440.00 million in 2025 and is projected to reach approximately USD 1,093.50 million by 2035, with a 9.53% CAGR from 2026 to 2035.

What Made North America the Dominant Region in the CAD Mammography Market in 2025?

North America led the CAD mammography market, capturing the largest share of 40% in 2025. The region's dominance in the market is driven by a strong healthcare infrastructure and widespread adoption of advanced imaging technologies. High awareness of breast cancer screening has also contributed to strong participation in regular mammography programs across the region. According to Breastcancer.org, breast cancer accounts for approximately 30% of all new cancer cases in 2026 among women in the U.S., reinforcing the need for widespread screening and advanced diagnostic tools such as digital mammography and AI-enabled CAD systems.

U.S. CAD Mammography Market Size and Growth 2026 to 2035

The U.S. CAD mammography market size is calculated at USD 330.00 million in 2025 and is expected to reach nearly USD 825.59 million in 2035, accelerating at a strong CAGR of 9.60% between 2026 and 2035.

U.S. CAD Mammography Market Trends

U.S. leads the market within North America due to its advanced screening infrastructure and early adoption of AI-enabled imaging technologies. High participation rates in screening programs are further increasing the use of mammography systems integrated with CAD solutions. Leading manufacturers such as Hologic Inc. and GE HealthCare continue to expand their AI-based mammography offerings in the country, strengthening market growth and technological advancement.

Europe: The Second-Largest Market

Europe is the second-largest market for CAD mammography, holding a 30% share in 2025, and is expected to grow at a strong CAGR of 6.5% over the projected period. This growth is driven by well-structured, government-supported breast cancer screening programs across multiple countries. According to the European Commission Initiative on Breast Cancer (2025), some member states have achieved screening coverage of over 80% of the target population through systematic screening efforts. Additionally, ongoing government support and the gradual integration of advanced diagnostic technologies are expected to further strengthen market growth.

Germany CAD Mammography Market Trends

Germany is a major contributor to the European market, owing to continuous investments in digital healthcare transformation. The country is actively upgrading its imaging infrastructure through government-funded initiatives within public healthcare systems. In addition, strong collaboration between research institutions and technology companies is accelerating innovation and adoption of advanced CAD solutions.

How is the Opportunistic Rise of Asia Pacific in the CAD Mammography Market?

Asia Pacific held a 20% share of the market in 2025 and is expected to grow at the fastest CAGR of 10.5% between 2026 and 2035. This growth is driven by rapid urbanization and increasing awareness of breast cancer, which is boosting demand for early detection services. In 2025, the International Agency for Research on Cancer reported a steady rise in breast cancer incidence in Asia, which accounts for more than 42.9% of the world's new cases. Moreover, companies such as Fujifilm Holdings Corporation and Canon Medical Systems Corporation are expanding their presence in the region, further supporting market growth.

China CAD Mammography Market Trends

In China, the market is driven by the rapid expansion of healthcare infrastructure and rising awareness of early cancer detection. The increasing incidence of breast cancer is further fueling demand for advanced diagnostic imaging technologies. In addition, large-scale digital health initiatives are facilitating the integration of CAD technologies into hospital systems, accelerating adoption across the country.

CAD Mammography Market Companies

• Agfa-Gevaert Group
• Canon Medical Systems Corporation
• Carestream Health, Inc.
• Fujifilm Holdings Corporation
• General Electric (GE) Healthcare
• Hologic, Inc.
• Konica Minolta, Inc
• Leica Microsystems (A Danaher Company)
• Mammotome (A subsidiary of Hologic)
• Medtronic PLC
• Merge Healthcare (IBM Watson Health)
• NDS Surgical Imaging
• Philips Healthcare
• Radiology Partners, Inc.
• Siemens Healthineers

Segments Covered in the Report

By Type

• 2D Mammography
• 3D Mammography (Tomosynthesis)

By Technology

• Full-Field Digital Mammography (FFDM)
• Analog Mammography
• Digital Breast Tomosynthesis (DBT)
• Contrast-Enhanced Mammography (CEM)

By End-Use

• Hospitals
• Diagnostic Imaging Centers
• Breast Cancer Screening Clinics
• Others

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa